• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


39.0000 USD 0.2200 0.57%

As of 14:07:57 ET on 08/29/2014.

Snapshot for Akorn Inc (AKRX)

Open: 38.7800 Day's Range: 38.7700 - 39.4500 Volume: 456,978
Previous Close: 38.7800 52wk Range: 17.7700 - 39.4800 1-Yr Rtn: +117.08%

Stock Chart for AKRX

No chart data available.
  • AKRX:US 39.0080
  • 1D
  • 1M
  • 1Y
Interactive AKRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKRX

Current P/E Ratio (ttm) 82.2406
Estimated P/E(12/2014) 39.0519
Relative P/E vs. SPX 4.5785
Earnings Per Share (USD) (ttm) 0.4754
Est. EPS (USD) (12/2014) 1.0020
Est. PEG Ratio 1.2338
Market Cap (M USD) 4,071.63
Shares Outstanding (M) 104.13
30 Day Average Volume 1,048,585
Price/Book (mrq) 13.7856
Price/Sale (ttm) 9.4415
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 08/29/1991
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKRX

Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

Rajat Rai "Raj"Chief Executive OfficerTimothy A Dick "Tom"CFO/Investor Relations
Bruce KutinskyChief Operating OfficerMark M SilverbergExec VP: Quality Assurance
More Company Profile & Key Executives for AKRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil